[HTML][HTML] Machine learning for the prediction of sepsis: a systematic review and meta-analysis of diagnostic test accuracy

…, T Guo, LF Roggeveen, EL Swart… - Intensive care …, 2020 - Springer
Purpose Early clinical recognition of sepsis can be challenging. With the advancement of
machine learning, promising real-time models to predict sepsis have emerged. We …

[HTML][HTML] Therapeutic drug monitoring by dried blood spot: progress to date and future directions

AJ Wilhelm, JCG den Burger, EL Swart - Clinical pharmacokinetics, 2014 - Springer
This article discusses dried blood spot (DBS) sampling in therapeutic drug monitoring
(TDM). The most important advantages of DBS sampling in TDM are the minimally invasive …

Systematic review on infusion reactions to and infusion rate of monoclonal antibodies used in cancer treatment

MD Rombouts, EL Swart… - Anticancer …, 2020 - ar.iiarjournals.org
Background: Patients with cancer who are treated with monoclonal antibodies are at risk for
developing infusion reactions. However, for some monoclonal antibodies, the incidence of …

Vitamin C pharmacokinetics in critically ill patients: a randomized trial of four IV regimens

…, AME Spoelstra-de Man, AR Girbes, EL Swart… - Chest, 2018 - Elsevier
Background Early high-dose IV vitamin C is being investigated as adjuvant therapy in
patients who are critically ill, but the optimal dose and infusion method are unclear. The …

[HTML][HTML] Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method

RWF Van Leeuwen, EL Swart, E Boven, FA Boom… - Annals of oncology, 2011 - Elsevier
Background In cancer patients, drug interactions may intensify adverse events or reduce
antitumour effects. We assessed the prevalence of potential drug interactions (PDIs) among …

Adherence and patients' experiences with the use of oral anticancer agents

…, CCLM Boons, F Kropff, PM van de Ven, EL Swart… - Acta …, 2014 - Taylor & Francis
A rapidly growing number of oral anticancer agents has become available in oncology and
hematology. Though these introductions have several benefits, medication adherence is an …

[HTML][HTML] Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock—a two-centre …

…, P Thoral, RM Van Hest, RAA Mathot, EL Swart… - Critical Care, 2022 - Springer
Background Adequate antibiotic dosing may improve outcomes in critically ill patients but is
challenging due to altered and variable pharmacokinetics. To address this challenge …

Comparative population pharmacokinetics of lorazepam and midazolam during long‐term continuous infusion in critically ill patients

EL Swart, KP Zuideveld, J De Jongh… - British journal of …, 2004 - Wiley Online Library
Aims It is well established that there is a wide intra‐and interindividual variability in dose
requirements for lorazepam and midazolam in intensive care patients. The objective of this …

Analysis of cyclosporin A, tacrolimus, sirolimus, and everolimus in dried blood spot samples using liquid chromatography tandem mass spectrometry

…, A Chahbouni, RM Vos, A Sinjewel, EL Swart - Analytical and …, 2012 - Springer
In the last few years, an increasing number of dried blood spot (DBS) sampling assays have
been developed. With this increase, more insight is gained in the factors that possibly …

Patient satisfaction with information on oral anticancer agent use

…, L Timmers, NM van Schoor, EL Swart… - Cancer …, 2018 - Wiley Online Library
Adequate information on oral anticancer agent (OACA) use is an essential element of
optimal cancer care. The present study aimed to get insight into the experiences of patients …